Updated Jul 16, 2026 · Last SEC filing 2026-07-01
GeneDx Holdings Corp. (WGS) has filed 20 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 3 Form 8-K material event filings were reported by WGS in the last 90 days. 2 Form 144 notices of proposed sale were filed for WGS stock. InsiderAlpha tracks every WGS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Services-Health Services (SIC 8000) |
|---|---|
| SEC CIK | 0001818331 |
| Form 4 filings (90d) | 20 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RUCH JOSHUA | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| Meister Keith A. | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| Leproust Emily M. | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| PFENNIGER RICHARD C JR | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| Ryan Jason | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| Casdin Eli | Insider | M — Option exercise | 3.6K | $0.00 | — | SEC | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 5.9K | $60.83 | $361K | SEC | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 2.4K | $61.50 | $149K | SEC | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | S — Open-market sale | 2.1K | $60.83 | $128K | SEC | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | M — Option exercise | 7.2K | $0.00 | — | SEC | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | S — Open-market sale | 760 | $59.75 | $45K | SEC | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | M — Option exercise | 18.8K | $0.00 | — | SEC | |
| Feeley Kevin | CHIEF FINANCIAL OFFICER | S — Open-market sale | 863 | $61.50 | $53K | SEC | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | S — Open-market sale | 2.1K | $59.75 | $128K | SEC | |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER | M — Option exercise | 6.5K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for GeneDx Holdings Corp. (WGS). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Meister Keith A. | 22 | $60.57M |
| Feeley Kevin | 14 | $339K |
| Stueland Katherine | 12 | $975K |
| Casdin Capital, LLC | 8 | $32.57M |
| Leproust Emily M. | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in WGS insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live WGS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.